Transmitted drug resistance to rilpivirine among antiretroviral‐naïve patients living with HIV from northern Poland
Introduction Rilpivirine (RPV) is a second‐generation non‐nucleoside reverse transcriptase inhibitor (NNRTI) that was recently approved for the treatment of antiretroviral‐naïve individuals with HIV‐1 viral load of <100,000 copies/ml. As transmission of the drug resistance mutations to this NNRTI...
| Автори: | , , , , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Wiley
2014-01-01
|
| Серія: | Journal of the International AIDS Society |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.7448/IAS.17.1.18929 |